1
Total deals
$3.3B
Total value
$3.3B
Avg deal
$3.3B
Largest
| # | Acquired | Date | Type | Status | Price | |
|---|---|---|---|---|---|---|
| 1 |
Viatris Biosimilars
Viatris Biosimilars is focused on the areas of oncology, immunology, endocrinolo…
|
2021-02-28 | Acquisition | Complete | $3.3B | Deal → |